نتایج جستجو برای: mucosal vaccines

تعداد نتایج: 87287  

2016
Kathrin Moor Sandra Y. Wotzka Albulena Toska Médéric Diard Siegfried Hapfelmeier Emma Slack

Our mucosal surfaces are the main sites of non-vector-borne pathogen entry, as well as the main interface with our commensal microbiota. We are still only beginning to understand how mucosal adaptive immunity interacts with commensal and pathogenic microbes to influence factors such as infectivity, phenotypic diversity, and within-host evolution. This is in part due to difficulties in generatin...

Journal: :PLoS ONE 2007
Eleonora Castelletti Sergio Lo Caputo Louise Kuhn Manuela Borelli Johanna Gajardo Moses Sinkala Daria Trabattoni Chipepo Kankasa Eleonora Lauri Alberto Clivio Luca Piacentini Dorothy H. Bray Grace M. Aldrovandi Donald M. Thea Francisco Veas Manuela Nebuloni Francesco Mazzotta Mario Clerici

BACKGROUND CCL28 (MEC) binds to CCR3 and CCR10 and recruits IgA-secreting plasma cells (IgA-ASC) in the mucosal lamina propria (MLP). Mucosal HIV-specific IgA are detected in HIV-infection and exposure. The CCL28 circuit was analyzed in HIV-infected and-exposed individuals and in HIV-unexposed controls; the effect of CCL28 administration on gastrointestinal MLP IgA-ASC was verified in a mouse m...

Journal: :The Journal of infectious diseases 1999
P N Fultz Q Wei L Yue

Inoculation of chimpanzees with human immunodeficiency virus type 1 (HIV-1) has been used as a model system to define mechanisms of pathogenesis and to test protective efficacy of candidate HIV-1 vaccines. In most of these studies, the animals were inoculated intravenously. However, because HIV-1 is transmitted primarily across mucosal surfaces, future evaluations of vaccines should employ muco...

2014
Yingying Xu Pak-Wai Yuen Jenny Ka-Wing Lam

Intranasal delivery of DNA vaccines has become a popular research area recently. It offers some distinguished advantages over parenteral and other routes of vaccine administration. Nasal mucosa as site of vaccine administration can stimulate respiratory mucosal immunity by interacting with the nasopharyngeal-associated lymphoid tissues (NALT). Different kinds of DNA vaccines are investigated to...

Journal: :Expert review of vaccines 2003
A Ruth Foxwell Jennelle M Kyd Allan W Cripps

Bacterial respiratory diseases remain a major cause of morbidity and mortality throughout the world. The young and the elderly are particularly susceptible to the pathogens that cause these diseases. Therapeutic approaches remain dependent upon antibiotics contributing to the persistent increases in antibiotic resistance. The main causes of respiratory disease discussed in this review are Mycob...

Journal: :Infection and immunity 2000
Q Zhang S Choo J Everard R Jennings A Finn

Previous studies in children have shown that Haemophilus influenzae type b (Hib) polysaccharide conjugate vaccines can reduce nasopharyngeal carriage of H. influenzae and provide herd immunity and suggest that this effect is mediated through mucosal antibodies. As this phenomenon may operate in other invasive bacterial infections which are propagated by nasopharyngeal carriage, mucosal antibody...

Journal: :Veterinary research 2006
Eric Cox Frank Verdonck Daisy Vanrompay Bruno Goddeeris

In developing veterinary mucosal vaccines and vaccination strategies, mucosal adjuvants are one of the key players for inducing protective immune responses. Most of the mucosal adjuvants seem to exert their effect via binding to a receptor/or target cells and these properties were used to classify the mucosal adjuvants reviewed in the present paper: (1) ganglioside receptor-binding toxins (chol...

2015
Hao Feng Han Zhang Jiusheng Deng Li Wang Yuan He Shelly Wang Roheila Seyedtabaei Qing Wang Laiting Liu Jacques Galipeau Richard W. Compans Bao-Zhong Wang

HIV vaccines should elicit immune responses at both the mucosal portals of entry to block transmission and systemic compartments to clear disseminated viruses. Co-delivery of mucosal adjuvants has been shown to be essential to induce effective mucosal immunity by non-replicating vaccines. A novel cytokine, GIFT4, engineered by fusing GM-CSF and interleukin-4, was previously found to simulate B ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید